RCKT:NASDAQ, Rocket Pharmaceuticals, Inc.

RCKT stock overview

Rocket Pharmaceuticals, Inc. (RCKT:NASDAQ) closed at $1.95 on November 20, 2026, down 7.58% on the day. The stock trades 64.2% below its 52-week high of $5.45 and 0.5% above its 52-week low of $1.94. Over the past year, it lost 25.7%. Rocket Pharmaceuticals, Inc. is part of the Health Care sector (Major Pharmaceuticals).

Key figures

Price
$1.95
Day change
-7.58%
Volume
2,895,040
Average volume
1,871,410
Market cap
217M+
52-week range
$1.94 – $5.45
50-day average
$2.59
200-day average
$3.36

Price action over the past year

In 252 trading sessions since November 19, 2025, RCKT closed higher on 116 days (46%). Its best day was March 9, 2026 (+15.87%) and its worst was March 27, 2026 (-19.62%). The stock moved 10% or more in a single session 5 times. It opened at least 5% above the previous day's high 2 times.

Recent signals

RCKT news

About Rocket Pharmaceuticals, Inc.

Inotek Pharmaceuticals Corp is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye.

Similar stocks

Find more stocks like RCKT with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.